UPMC Physician Resources

Hawaiian Eye 2015

At this year’s Hawaiian Eye conference taking place from January 17 – 23, Joel S. Schuman, MD, FACS, will be presenting and moderating the Glaucoma session. Dr. Schuman’s presentation, How to Use OCT in Deciding Whether or Not to Intervene in Glaucoma, will share results of a recent study that showed with OCT we can detect glaucoma earlier than ever before.

Ocular Surgery News featured a summary of Dr. Schuman’s presentation online. It is available here.

The full list of presentations is available here.

Joel S. Schuman, MD, Interviewed by UCSD Shiley Eye Center

Joel S. Schuman, MD, FACS, was recently interviewed for the UC San Diego Shiley Eye Center podcast series. Dr. Schuman discussed changes in glaucoma over the last few years, including changes in medicine and diagnostic tools.

The full interview is also available here.




Autologous alternative veins do not provide better mid term outcomes than prosthetic conduits for below knee bypass when great saphenous vein is unavailable

Efthymios Avgerinos, MD, presented “Autologous Alternative Veins do not Provide Better mid-term outcomes than Prosthetic Conduits for below knee bypass when Great Saphenous Vein is Unavailable” at the European Society of Vascular Surgery 2014 Meeting in Stockholm, Sweden.

He discussed how certain patients with peripheral vascular disease who need a surgical bypass can benefit from contemporary prosthetic conduits when great saphenous vein (the gold standard conduit) is unavailable. Current recommendations suggest that when great saphenous vein is unavailable in a patient needing a surgical bypass for limb salvage, an alternative vein (e.g. arm vein) should be preferred over a prosthetic graft. Usage of alternative veins requires a complex, lengthy, high risk procedure that may be associated with significant adverse events and multiple reinterventions.

Dr Avgerinos’ research identified a subgroup of patients for whom a prosthetic conduit can have equal if not better postoperative and mid-term outcomes. Using a prosthetic conduit minimizes the incisions needed and the operative time. Patients who should preferentially receive a prosthetic conduit would be those with multiple comorbidities and those whose bypass target is the below knee popliteal artery.

Read the abstract here.

Hear more about this work from Dr. Avgerinos:


The what, why, who and how of pneumatic retinopexy

The December “News You Can Use” column in Ocular Surgery News featured an article by Andrew Eller, MD. Dr. Eller discussed the benefits and who makes a good candidate for pneumatic retinopexy. The full article is available here.

What is the role and who is a good candidate?

What are the benefits to pneumatic retinopexy?

How does pneumatic retinopexy work?

What is the risk of a failed pneumatic retinopexy procedure?

Follow up questions for Dr. Eller can be directed to EyeCenter@upmc.edu

UPMC Vascular Surgeon Elected to lead Regional Quality Group

Donald Baril, MD, chief of vascular surgery at UPMC Mercy, has been named the medical director of the Vascular Quality Initiative’s (VQI) Great Lakes Vascular Study Group.

The VQI is overseen by the Society for Vascular Surgeons Patient Safety Organization which provides oversight of data sharing arrangements, quality measures, and distribution of information to participating providers and functions as a collective of regional quality groups gathering and evaluating data in an effort to improve the quality, safety and effectiveness of patient care.

The Great Lakes Vascular Study Group covers western Pennsylvania and parts of eastern Ohio.

Nasolacrimal duct obstruction a common condition in children

The November News You Can Use column in Ocular Surgery News featured Ellen Mitchell, MD. Dr. Mitchell discussed nasolacrimal duct obstruction and various treatment methods. The full article is available on Ocular Surgery News.

1. What symptoms can a patient present with that may indicate a diagnosis of NLDO? 

2.What does the conservative method of treating NLDO include?

3. What are the advantages of waiting for probing and irrigation?

4.What are the available treatment options if symptoms recur ?

Questions or comments can be directed to Dr. Mitchell at EyeCenter@upmc.edu.

Clinical findings and management of neurotrophic keratopathy

The October “News You Can Use” column featured an article from new UPMC Eye Center faculty member Ladan Espandar, MD. Dr. Espandar discussed neurotrophic keratopathy. The full article is available here. 

What is neurotrophic keratopathy and what causes it?

What are the clinical findings and how do they differ?

How is this condition treated?

Questions can be directed to Dr. Espandar at EyeCenter@upmc.edu

Right-ventricular Dysfunction and Prognosis in Patients with Low-flow, Low-gradient Severe Aortic Stenosis

João Cavalcante, MD, presented “Right-ventricular dysfunction and prognosis in patients with low-flow, low-gradient severe aortic stenosis,” at the European Society of Cardiology 2014 Meeting in Barcelona, Spain. He discussed how assessment of aortic stenosis (AS) severity is critical for treatment decisions but challenging in patients with severe AS and low gradients. The research further examines the importance of the interplay between the two ventricles in patients with aortic stenosis and heart failure.

Read the full abstract here (page 250).

Hear more about this work from Dr. Cavalcante:

American Academy of Ophthalmology 2014

The American Academy of Ophthalmology 2014 Annual Meeting will be taking place later this month in Chicago. A number of UPMC Eye Center physicians will be participating in this year’s conference.

Joel S. Schuman, MD, FACS, chair, UPMC Eye Center, is presenting the courses, OCT: Interpretation & Clinical Applications and Evidence-Based Guidelines in the Management of Glaucoma.

Deepinder Dhaliwal, MD, is presenting during the symposium Update 2014: Infectious Keratitis and The Great Debate: Cornea.

Ken Nischal, MD, is scheduled to present the courses Pediatric Corneal Disorders: A Comprehensive Overview and Nightmares in Pediatric Cataract Surgery.

Thomas Friberg, MD, is scheduled to participate in Academy Cafe – Retina.

For questions about the above presentations, please email EyeCenter@upmc.edu

Chemotherapy and SABR May Be Promising Treatment for Advanced Pancreatic Cancer

Pancreatic cancer is often diagnosed at a late stage with locally advanced disease making surgery to remove the tumor difficult. A recent study at UPMC CancerCenter, partner with University of Pittsburgh Cancer Institute, evaluated patients treated with a combination of chemotherapy and stereotactic ablative radiation (SABR). With a total of 34 patients in the trial, 31 patients completed chemotherapy. Of those 31 patients, 12 went on to have surgery to remove the tumor. After the surgery, 90 percent of the patients had no local disease.

These findings were recently presented at the 56th Annual American Society for Radiation Oncology (ASTRO) meeting. Watch Kimmen Quan, MD,  radiation oncologist at UPMC, discuss this study.

Page 5 of 20:« First« 2 3 4 5 6 7 8 »Last »
  • Make A Referral

    To refer a patient, call UPMC’s 24-hour physician referral service at 1-800-544-2500 or e-mail us.
  • Information for your Patients

    UPMC’s Clinical Services page provides information for your patients on services, conditions, and treatments.